Search Result "VEGFR-2 inhibitors."
Design, Synthesis and Biological Evaluation of Uracil Derivatives as Novel VEGFR-2 Inhibitors
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 6 Year: 2018 Page: 734-740
Author(s): Jingwei Liang,Xinyang Li,Su Yang,Xin He,Mingyang Wang,Fanhao Meng
Molecular Insight and Binding Pattern Analysis of Shikonin as a Potential VEGFR-2 Inhibitor
Journal: Current Enzyme Inhibition
Volume: 13 Issue: 3 Year: 2017 Page: 235-244
Author(s): Raju Dash,Md. Junaid,Nazrul Islam,Md. Forhad Chowdhury Akash,Md. Imran Khan,Md. Arifuzzaman,Mahmuda Khatun,S. M. Zahid Hosen
Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 13 Year: 2021 Page: 2540-2564
Author(s): Kang Cheng,Chen-Fu Liu,Guo-Wu Rao
Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 10 Year: 2016 Page: 1000-1040
Author(s): Leilei Shi,Jianfeng Zhou,Jifeng Wu,Yuemao Shen,Xun Li
Pharmacophore Generation and 3D-QSAR of Novel 2-(quinazolin-4- ylamino)-[1,4] Benzoquinone Derivatives as VEGFR-2 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 10 Year: 2012 Page: 899-914
Author(s): Mahesh Kumar Teli,Pradeep Hanumanthappa,Rajanikant G. Krishnamurthy
Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase
Journal: Current Computer-Aided Drug Design
Volume: 13 Issue: 3 Year: 2017 Page: 186-207
Author(s): Heena R. Bhojwani,Urmila J. Joshi
Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazolelinked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 11 Year: 2022 Page: 2166-2180
Author(s): Nishtha Shalmali,Sandhya Bawa,Md Rahmat Ali,Sourav Kalra,Raj Kumar,Bushra Zeya,Moshahid Alam Rizvi,Sangh Partap,Asif Husain
Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis,and Anti-proliferative Studies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 18 Year: 2023 Page: 2042-2055
Author(s): Sachin A. Dhawale,Pratap S. Dabhade,Santosh N. Mokale
New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies
Journal: Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2024 Page: 876-899
Author(s): Eman A. Sobh,Mohammed A. Dahab,Eslam B. Elkaeed,Bshra A. Alsfouk,Ibrahim M. Ibrahim,Ahmed M. Metwaly,Ibrahim H. Eissa
Molecular Design and Synthesis of New 3,4-Dihydropyrimidin-2(1H)-Ones as Potential Anticancer Agents with VEGFR-2 Inhibiting Activity
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2019 Page: 310-322
Author(s): Amany S. Mostafa,Waleed A. Bayoumi,Mohamed El-Mesery,Abdelaziz Elgaml